37
Participants
Start Date
February 28, 2011
Primary Completion Date
December 31, 2014
Study Completion Date
December 31, 2014
Docetaxel
"The study medication will be administered every 3 weeks for a maximum of 8cycles. A study medication will be given to the patients.~* Docetaxel (-1 to 3 level)mg/m2 IV(D1) every 21 days (-1 level: 40, 1 level: 60, 2 level: 80, 3 level: 100)~* Xeloda 937.5 mg/m2/ day PO, twice a day(D1-D14) every 21 days~* Cisplatin 60mg/m2 IV (D1) every 21 days"
Asan Medical Center, Seoul
Lead Sponsor
Asan Medical Center
OTHER